Method and Device for Utilizing Analyte Levels to Assist in the Treatment of Diabetes
2 Assignments
0 Petitions
Accused Products
Abstract
A health-monitoring device assesses the health of a user based on levels of two analytes in a biological fluid. A first analyte that is utilized to assess a user'"'"'s health is a fat metabolism analyte, such as ketones, free fatty acids and glycerol, which is indicative of fat metabolism. A second analyte that is utilized is a glucose metabolism analyte, such as glucose. The levels of the two analytes may be used to assess insulin sensitivity, to detect both recent hypoglycemia and the cause of high glucose levels, and/or to guide therapeutic intervention. The dual analyte model may calculate a discrepancy between an actual insulin activity level and a theoretical insulin activity level. The dual analyte model of the present invention may be used to identify individuals at risk for metabolic syndrome, insulin resistance and non-insulin dependent diabetes, and allows monitoring of the progression of those disease states, as well as progress made by therapeutic interventions.
20 Citations
85 Claims
-
1-20. -20. (canceled)
-
21. A health-monitoring device for monitoring the health of a user, the device comprising:
-
a testing device to measure a concentration of a glucose analyte and a concentration of a fat analyte in a user and generate a signal indicative of the concentrations of the glucose and fat analytes; a processor comprising programming to calculate the concentration of the glucose analyte and the concentration of the fat analyte based on the signal and determine a correlation between the concentrations of the glucose and fat analytes and a health parameter indicative of the user'"'"'s health, wherein the health parameter comprises an insulin sensitivity factor, a medication dosage, an assessment of a metabolic syndrome, a likelihood of the user developing hypoglycemia, a likelihood of the user developing hyperglycemia or a likelihood that the user recently developed hypoglycemia; and a user interface comprising an input to receive information from the user and a display to display at least one of the concentration of the glucose analyte, the concentration of the fat analyte and the health parameter. - View Dependent Claims (22, 23, 24, 25, 26, 27, 28, 30, 31, 32, 33, 34, 65, 66)
-
-
35. A method for monitoring the health of a user, the method comprising:
-
measuring, using a testing device, a concentration of a glucose analyte and a concentration of a fat analyte in a user; generating, using the testing device, a signal indicative of the concentrations of the glucose and the fat analytes; calculating, using a processor, the concentration of the glucose analyte and the concentration of the fat analyte based on the signal; determining, using the processor, a correlation between the concentrations of the glucose and the fat analytes and a health parameter indicative of the user'"'"'s health, wherein the health parameter comprises an insulin sensitivity factor, a medication dosage, an assessment of a metabolic syndrome, a likelihood of the user developing hypoglycemia, a likelihood of the user developing hyperglycemia and a likelihood that the user recently developed hypoglycemia; receiving information from the user through a user interface; and displaying on a display at least one of the concentration of the glucose analyte, the concentration of the fat analyte and the health parameter. - View Dependent Claims (36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52)
-
-
53. A health monitoring system for monitoring the health of a user, the system comprising:
-
a health-monitoring device comprising; a testing device to measure a concentration of a glucose analyte and a concentration of a fat analyte in a user and generate a signal indicative of the concentrations of the glucose and the fat analytes; a processor comprising programming to calculate a concentration of the glucose analyte and a concentration of the fat analyte based on the signal and determine a correlation between the concentrations of the glucose and the fat analytes and a health parameter indicative of the user'"'"'s health, wherein the health parameter comprises an insulin sensitivity factor, a medication dosage, an assessment of a metabolic syndrome, a likelihood of the user developing hypoglycemia, a likelihood of the user developing hyperglycemia or a likelihood that the user recently developed hypoglycemia; a user interface comprising an input to receive information from the user and a display to display at least one of the concentration of the glucose analyte, the concentration of the fat analyte and the health parameter; and a first data communication port; and a remote site comprising a second data communication port, wherein the first data communication port and the second data communication port communicate data between the health-monitoring device and the remote site. - View Dependent Claims (54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 67)
-
-
68. A program executable by a processor of a health monitoring system, the program comprising instructions for operating the system to perform the steps of:
-
measuring, using a testing device, a concentration of a glucose analyte and a concentration of a fat analyte in a user; generating, using the testing device, a signal indicative of the concentrations of the glucose and the fat analytes; calculating, using the processor, the concentration of the glucose analyte and the concentration of the fat analyte based on the signal; determining, using the processor, a correlation between the concentrations of the glucose and fat analytes and a health parameter indicative of the user'"'"'s health, wherein the health parameter comprises an insulin sensitivity factor, a medication dosage, an assessment of a metabolic syndrome, a likelihood of the user developing hypoglycemia, a likelihood of the user developing hyperglycemia or a likelihood that the user recently developed hypoglycemia; receiving information from the user through a user interface; and displaying on a display at least one of the concentration of the glucose analyte, the concentration of the fat analyte and the health parameter. - View Dependent Claims (69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85)
-
Specification